ArticleJournal for immunotherapy of cancer2023

FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report.

Nicolas Roussot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.